Trial Profile
A Phase II, Open-Label, Safety, Efficacy and Pharmacodynamic Study of oral sonidegib in patients with Basal Cell Carcinoma (BCC) and prior exposure to Hedgehog Pathway inhibitors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2014
Price :
$35
*
At a glance
- Drugs Sonidegib (Primary) ; Vismodegib
- Indications Basal cell cancer
- Focus Therapeutic Use
- Acronyms SALSA
- 12 Aug 2014 New trial record
- 12 Aug 2014 New trial record